Cancer Library
Tips for getting through treatment with a radiation therapy mask
Icon Group has extended its relationship with Magentus, signing a new five-year contract for the continued use of the Charm oncology information management system.
This renewed agreement builds upon a successful initial contract signed in 2016, which has seen the implementation of Charm across all Integrated Icon Cancer Centre sites in Australia.
Charm empowers healthcare providers like Icon Group to streamline workflows, reduce treatment durations and wait times, and enhance patient care.
By digitising manual processes, the system supports adherence to best practice clinical guidelines and improves clinical safety by minimising transcription errors and enabling real-time adjustments to treatment plans based on patient needs.
Mark Middleton OAM, CEO of Icon Group, said:
“By connecting crucial patient information into a single, digital record, Charm provides a centralised source of truth for the entire care team. This empowers clinicians to make informed decisions and deliver the highest quality care with improved efficiency and accuracy.
Our new agreement with Magentus to extend our use of Charm highlights our focus on investing in evidence-based medicine and innovative digital solutions to deliver quality patient care.”
Pictured: Icon Group CEO, Mark Middleton OAM and Magentus Managing Director (Practice Management and Oncology), Michele Blanshard.
Magentus is delighted to continue our partnership with Icon Group. By streamlining workflows and reducing administrative burdens, Charm empowers clinicians to focus on what matters most: providing exceptional patient care. The improved accuracy and timeliness of pharmacy orders and drug supply are also significant benefits of the Charm system.
Magentus Managing Director (Practice Management & Oncology
“Magentus is delighted to continue our partnership with Icon Group. By streamlining workflows and reducing administrative burdens, Charm empowers clinicians to focus on what matters most: providing exceptional patient care. The improved accuracy and timeliness of pharmacy orders and drug supply are also significant benefits of the Charm system.”
Rachael Powell, Magentus CEO, said:
“This renewed partnership with Icon Group underscores the growing importance of robust, interoperable oncology solutions. We are proud to support Icon Group in their mission to deliver exceptional cancer care and are committed to continually enhancing the system to meet evolving needs.”
Explore more from Icon
Discover our comprehensive collection of content designed to inform, support, and guide you through every aspect of cancer care. From the latest news and updates to personal patient experiences and educational resources, these materials provide valuable insights to help you better understand cancer, treatment options, and the journey ahead.
